First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with

Tsuyoshi Matsunaka1, Mareomi Hamada, Yuji Matsumoto

  • 1The Second Department of Internal Medicine, Ehime University School of Medicine, Japan.

Abstract

Insights

Abnormal signal intensity on MRI, including first-pass myocardial perfusion defects and delayed contrast enhancement, correlates with reduced left ventricular contractile function in hypertrophic cardiomyopathy patients.

Area of Science:

  • Cardiovascular Imaging
  • Cardiology
  • Radiology

Background:

  • Gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) enhanced MRI is valuable for detecting myocardial injury.
  • Hypertrophic cardiomyopathy (HCM) is characterized by abnormal heart muscle thickening.

Purpose of the Study:

  • To investigate the relationship between abnormal signal intensity on MRI and left ventricular regional contractile function in HCM patients.
  • To assess the utility of first-pass myocardial perfusion and delayed contrast-enhanced MRI in HCM.

Main Methods:

  • Twelve HCM patients underwent cine imaging, first-pass myocardial perfusion imaging, and delayed contrast-enhanced MRI.
  • Images were divided into blocks for analysis of signal intensity, wall thickness, and contractile function.

Main Results:

  • Perfusion defects (PD) and delayed enhancement (DE) were common in HCM patients.
  • Areas with PD and DE showed increased wall thickness compared to normal areas.
  • Reduced percent wall thickening was observed in blocks with PD and DE, correlating significantly with their presence.

Conclusions:

  • Abnormal signal intensity on first-pass myocardial perfusion and delayed contrast-enhanced MRI is closely linked to impaired left ventricular regional contractile function in HCM.
  • These MRI techniques can help assess contractile dysfunction in HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...